I look forward to working with the Interaxon team as we evolve digital health technology and develop new products to improve clinical care and promote individual health and wellness.”ĭr. Developing next-generation medical products is key to addressing several challenges that our society is facing – the current pandemic of course, but also the looming problems generated by an aging population and the associated burden on our healthcare infrastructure. “The team at Interaxon has developed an extremely sophisticated multi-sensor medical wearable system.
This is a pivotal time in the evolution of healthcare - medical product developers must work at full speed and with focused attention to improve the way we provide clinical assessments and medical therapies, or our over-strained healthcare system will not evolve to match the growing demand,” says Dr. “I’m excited to be working with the team at Interaxon to help move digital health technology forward. Greenleaf helped start the California State University Center for Disability Solutions and serves as Board Chair for the International Virtual Reality Health Association (IVRHA). He previously served as the Director of the Mind Division, Stanford Center on Longevity, where his focus was on age-related changes in cognition Dr. He has served as a Principal Investigator for research grants funded by NIH and NASA. Public Health Service, National Science Foundation (NSF), National Institutes of Health (NIH), NASA and the U.S. Walter has served as a scientific advisor and grant reviewer for the U.S. He also serves as the Director of Technology Strategy for the National Mental Health Innovation Center at the University of Colorado. Greenleaf currently holds academic positions as the Medical VR/AR Expert at the Stanford Virtual Human Interaction Lab and as a MediaX Distinguished Visiting Scholar, both at Stanford University.
0 kommentar(er)
